Ten hyperthermic isolation-perfusions with melphalan were performed for invasive malignant melanoma of the limbs. Four cases at stage II and with in transit metastases (up to 15 cm in diameter) had a complete regression. However, no improvement of survival was noticed: 4 out of 5 stage II patients who died, within 1 year after perfusion, developed a generalized disease. Systemic chemotherapy was administered in 3 patients after perfusion, but they died from distant metastases. The need for an adequate adjuvant treatment added to isolation perfusion is discussed.
Get full access to this article
View all access options for this article.
References
1.
BergelF., StockJ. A.: Cytotoxic alpha amino-acids and peptides. 31st Ann. Rep. British Empire Cancer Campain, p. 6, 1953.
2.
CreechO.Jr., KrementzE.T., RyanR. F., WinbladJ. N.: Chemotherapy for cancer. Regional perfusion utilizing an extracorporeal circuit. Ann Surg., 148: 616, 632, 1958.
3.
De WaschG., BernheimJ., MichelJ., LejeuneF., KenisY.: Combination chemotherapy with 3 marginally effective agents, CCNU, vincristine and bleomycin, in the treatment of stage III melanoma. Cancer Treat. Rep., 60: 1273–1276, 1976.
4.
KrementzE. T., KnudsonL.: The effect of increased oxygen tension on the tumoricidal effect of nitrogen mustard. Surgery, 50: 266–273, 1961.
5.
KrementzE. T., RyanR. F.: Chemotherapy of melanoma of the extremities by perfusion: Fourteen years clinical experience. Ann. Surg., 175: 900–917, 1972.
LebrunJ., SmetsW.: La perfusion régionale par circulation extra-corporelle. Technique chirurgicale permettant l'administration d'agents chimiothérapiques anti-cancéreux à doses élevées. Acta Chir. Belg., 60: 368–405, 1961.
8.
MatheG., KenisY.: Les cancers cutanés et le mélanome malin. pp. 415–423. In: La Chimiothérapie des Cancers.Expansion Scientifique Française, Paris, 1975.
9.
Mc BrideC. M., ClarkR. L.: Experience with I-phenylalanine mustard dihydrochloride in isolation perfusion of extremities for malignant melanoma. Cancer, 28: 1293–1296, 1971.
10.
Mc BrideC. M., SugarbakerE. V., HickeyR. C.: Prophylactic isolation perfusion as the primary therapy for invasive malignant melanoma of the limbs. Ann. Surg., 182: 316–324, 1975.
11.
RochlinD. B., SmartC. R.: Treatment of malignant melanoma by regional perfusion. Cancer, 18: 1544–1550, 1965.
12.
Schraffordt-KoopsH., OldhoffJ., Van der PloegE., VermeyA., EiberyenR.: Isolated regional perfusion in the treatment of malignant melanomas of the extremities. Arch. Chir. Neerl., 27: 237–243, 1975.
13.
ShingletonW. W.: Perfusion chemotherapy for recurrent melanoma of extremity: A progress report. Ann. Surg., 169: 969–973, 1969.
14.
StehlinJ. S.Jr., ClarkR. L.: Melanoma of the extremities; experiences with conventional treatment and perfusion in 339 cases. Am. J. Surg., 110: 366–383, 1965.
15.
StehlinJ. S.Jr., GiovanellaB. C., de IpolyiP. D., MuenzL. R., AndersonR. F.: Results of hyperthermic perfusion for melanoma of the extremities. Surg. Gynec. Obstet., 140: 338–348, 1975.
16.
WeaverP. C., WrightJ., BranderW. L., WestburyG.: Salvage procedures for locally advanced malignant melanoma of the lower limb (with special reference to the role of isolated limb perfusion and radical lymphadenectomy). Clin. Oncol., 1: 45–51, 1975.
